Spyre Therapeutics Inc (FRA:3920)
€ 31.7 0.8 (2.59%) Market Cap: 1.62 Bil Enterprise Value: 1.47 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Spyre Therapeutics Inc (FRA:3920) Transcripts

  • 1